Appleby, Julie. <br/><br/>
Consumers Pay As Drug Firms Fight over Generics. / 
Julie Appleby and Jayne O'Donnell. 
 -  Gannett News Service (Syndicate),  2002. 
 - SIRS Enduring Issues 2003.  Article 74.  Business,  1522-3191; .
<br/><br/> Articles Contained in SIRS Enduring Issues 2003.  Originally Published: Consumers Pay As Drug Firms Fight over Generics, June 6, 2002; pp. 1A-2A. 
<br/><br/> "Drug companies are finding it to their advantage to file additional patents on existing drugs. Such moves can keep lower-cost generics off the market for years." (USA TODAY) This article suggests that drug companies are filing for unnecessary patent extensions "to delay rivals as long as possible, knowing that prices and their own market share for top-selling products can drop by half or more once generics hit the market.". 
<br/><br/><label>ISSN: </label>1522-3191; 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Consumer protection.<br/>Drugs--Prices.<br/>Generic drugs.<br/>Patents.<br/>Paxil.<br/>Pharmaceutical industry.
<br/><br/><label>LC Class. No.: </label>AC1.S5 
<br/><br/><label>Dewey Class. No.: </label>050